Clear efficacy demonstration means more confident strategic compound decisions—but patient variability complicates decision-making at every level, from study conduct to data analysis. Treatment nonadherence and dropout, patient heterogenicity and placebo response are all gaps that affect statistical significance. Predict patient behavior, bridge knowledge gaps, and prevent therapies from failing for the wrong reasons.